Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-07

FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a supplemental application for ABSORICA LD (isotretinoin) from Sun Pharmaceutical Industries, Inc. This action approves a supplement to the existin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABSORICA LD (isotretinoin)

Snippet

SUPPL AP for ABSORICA LD (ISOTRETINOIN)